- Home
- KVHI vs IKNA Comparison
KVHI vs IKNA Comparison
Compare KVHI & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KVHI
- IKNA
- Stock Information
- Founded
- KVHI 1978
- IKNA 2016
- Country
- KVHI United States
- IKNA United States
- Employees
- KVHI N/A
- IKNA N/A
- Industry
- KVHI Radio And Television Broadcasting And Communications Equipment
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- KVHI Technology
- IKNA Health Care
- Exchange
- KVHI Nasdaq
- IKNA Nasdaq
- Market Cap
- KVHI 90.5M
- IKNA 82.5M
- IPO Year
- KVHI 1996
- IKNA 2021
- Fundamental
- Price
- KVHI $5.11
- IKNA $1.69
- Analyst Decision
- KVHI
- IKNA Buy
- Analyst Count
- KVHI 0
- IKNA 2
- Target Price
- KVHI N/A
- IKNA $3.00
- AVG Volume (30 Days)
- KVHI 36.1K
- IKNA 65.3K
- Earning Date
- KVHI 11-07-2024
- IKNA 11-07-2024
- Dividend Yield
- KVHI N/A
- IKNA N/A
- EPS Growth
- KVHI N/A
- IKNA N/A
- EPS
- KVHI N/A
- IKNA N/A
- Revenue
- KVHI $118,366,000.00
- IKNA $659,000.00
- Revenue This Year
- KVHI N/A
- IKNA N/A
- Revenue Next Year
- KVHI N/A
- IKNA N/A
- P/E Ratio
- KVHI N/A
- IKNA N/A
- Revenue Growth
- KVHI N/A
- IKNA N/A
- 52 Week Low
- KVHI $4.17
- IKNA $1.22
- 52 Week High
- KVHI $5.49
- IKNA $2.32
- Technical
- Relative Strength Index (RSI)
- KVHI 67.80
- IKNA 44.68
- Support Level
- KVHI $4.35
- IKNA $1.71
- Resistance Level
- KVHI $4.65
- IKNA $1.76
- Average True Range (ATR)
- KVHI 0.20
- IKNA 0.05
- MACD
- KVHI 0.05
- IKNA -0.00
- Stochastic Oscillator
- KVHI 86.36
- IKNA 20.00
About KVHI KVH Industries Inc.
KVH Industries Inc provide integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. The Company operates in a number of geographic areas, including internationally. The Revenues are generated from international locations, mainly consisting of Singapore, Canada, European Union countries and other European countries, countries in Africa, Asia/Pacific and the Middle East, and India.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.